Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1606c902b61b164197a5c51f8dd4724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fce211ef4d15111724aaaddb9acc7763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2afd95f5193e5cf73cf8877c92a34b9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 |
filingDate |
2010-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcfbda0f3807b3afee757084b7d7d002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc738fdbd494e68e1d7efd165e89906 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02c0d136433474aad2a1d24d1fd2120a |
publicationDate |
2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010112497-A1 |
titleOfInvention |
Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response |
abstract |
The invention relates to the use of domperidone or a pharmaceutically acceptable salt thereof at low doses to prevent and/or treat a disease associated with an alteration of the immune response such as Leishmaniosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3949965-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022028839-A1 |
priorityDate |
2009-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |